Edition:
United Kingdom

People: Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

5.66USD
22 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$5.66
Open
$5.59
Day's High
$5.66
Day's Low
$5.59
Volume
4,016
Avg. Vol
5,337
52-wk High
$7.00
52-wk Low
$5.11

Cearnal, Martin 

Mr. Martin E. Cearnal is Senior Vice President, Chief Commercial Officer and Director of Cumberland Pharmaceuticals Inc. In 2008, he joined our management team to head commercial development for Cumberland, currently serving as Senior Vice President and Chief Commercial Officer. He is the former President and Chief Executive Officer of Physicians World, which became the largest provider of continuing medical education during his tenure from 1985 to 2000. Physicians World was acquired by Thomson Healthcare in 2000, and Mr. Cearnal served as President of Thomson Physicians World from 2000 to 2003 and Executive Vice President-Chief Strategy Officer for Thomson Medical Education from 2003 through 2005. He then became Executive Vice President-Chief Strategy Officer for Jobson Medical Information. Mr. Cearnal has 45 years of experience in the healthcare industry and has been involved with the launches of such noteworthy pharmaceutical products as Lipitor®, Actos®, Intron-A®, Straterra®, Botox® and Humira®. He spent 17 years at Revlon Healthcare in a variety of domestic and international pharmaceutical marketing roles culminating in his position as Vice President, Marketing for International Operations. He has a B.S. degree from Southeast Missouri State University.

Basic Compensation

Total Annual Compensation, USD 329,500
Restricted Stock Award, USD 13,740
Long-Term Incentive Plans, USD --
All Other, USD 40,000
Fiscal Year Total, USD 383,240

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 160,000 204,800.00
Name Fiscal Year Total

A. Kazimi

995,950

Michael Bonner

--

Martin Cearnal

383,240

Leo Pavliv

472,100

James Herman

299,745

Amy Rock

--
As Of  31 Dec 2014